More on BCTXZ

- Summary
- Chart
- Profile
- Historical

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:BCTXZ)
Delayed: 0.09 -0.01 (10%)
Prev. Close $0.10  
Open$0.10 
52 Wk High$ 
52 Wk Low$ 
Day High$0.10 
Day Low$0.08 
P/E N/A  
EPS$ 
Volume163,894 

Friends, Peers and Foes (?): BCT, BCTX BCTXW (more...)

May 31, 2026 07:59 PM BriaCell Therapeutics Announces Pricing of Offering
May 15, 2026 07:30 AM BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
May 14, 2026 07:30 AM BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer
May 13, 2026 07:30 AM BriaCell adds Penn Medicine cancer center to phase 3 breast cancer trial
May 13, 2026 07:30 AM BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
May 12, 2026 07:30 AM BriaCell enrolls over 230 patients in phase 3 breast cancer study
May 12, 2026 07:30 AM BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients
May 7, 2026 07:30 AM BriaCell adds NYU cancer center to phase 3 breast cancer trial
May 7, 2026 07:30 AM BriaCell Adds NYU Langone Health’s Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
May 6, 2026 07:30 AM BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer
View All Articles

Entities mentioned with BCTXZ

View All Entities